<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ohkawara B</submitter><funding>NINDS NIH HHS</funding><pagination>1856-68</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3943522</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(7)</volume><pubmed_abstract>Congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms. Using Sanger and exome sequencing in a CMS patient, we identified two heteroallelic mutations, p.Glu1233Lys and p.Arg1277His, in LRP4 coding for the postsynaptic low-density lipoprotein receptor-related protein 4. LRP4, expressed on the surface of the postsynaptic membrane of the neuromuscular junction, is a receptor for neurally secreted agrin, and LRP4 bound by agrin activates MuSK. Activated MuSK in concert with Dok-7 stimulates rapsyn to concentrate and anchor AChR on the postsynaptic membrane and interacts with other proteins implicated in the assembly and maintenance of the neuromuscular junction. LRP4 also funct</pubmed_abstract><journal>Human molecular genetics</journal><pubmed_title>LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.</pubmed_title><pmcid>PMC3943522</pmcid><funding_grant_id>R01 NS006277</funding_grant_id><funding_grant_id>NS6277</funding_grant_id><funding_grant_id>R56 NS006277</funding_grant_id><pubmed_authors>Milone M</pubmed_authors><pubmed_authors>Nakata T</pubmed_authors><pubmed_authors>Engel AG</pubmed_authors><pubmed_authors>Ohkawara B</pubmed_authors><pubmed_authors>Ito K</pubmed_authors><pubmed_authors>Asai N</pubmed_authors><pubmed_authors>Ito Y</pubmed_authors><pubmed_authors>Masuda A</pubmed_authors><pubmed_authors>Ohno K</pubmed_authors><pubmed_authors>Ito M</pubmed_authors><pubmed_authors>Cabrera-Serrano M</pubmed_authors></additional><is_claimable>false</is_claimable><name>LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.</name><description>Congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms. Using Sanger and exome sequencing in a CMS patient, we identified two heteroallelic mutations, p.Glu1233Lys and p.Arg1277His, in LRP4 coding for the postsynaptic low-density lipoprotein receptor-related protein 4. LRP4, expressed on the surface of the postsynaptic membrane of the neuromuscular junction, is a receptor for neurally secreted agrin, and LRP4 bound by agrin activates MuSK. Activated MuSK in concert with Dok-7 stimulates rapsyn to concentrate and anchor AChR on the postsynaptic membrane and interacts with other proteins implicated in the assembly and maintenance of the neuromuscular junction. LRP4 also funct</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Apr</publication><modification>2026-04-16T01:17:31.673Z</modification><creation>2019-03-27T01:22:43Z</creation></dates><accession>S-EPMC3943522</accession><cross_references><pubmed>24234652</pubmed><doi>10.1093/hmg/ddt578</doi></cross_references></HashMap>